threonine has been researched along with sk&f-38393 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clementi, M; Croke, DT; Drago, J; Dunleavy, M; Fienberg, AA; Fisone, G; Greengard, P; Hakansson, K; Henshall, DC; Kinsella, A; O'Sullivan, GJ; Sibley, DR; Waddington, JL | 1 |
| Bateup, HS; Higashi, H; Kuroiwa, M; Nishi, A; Shuto, T; Tanaka, M | 1 |
2 other study(ies) available for threonine and sk&f-38393
| Article | Year |
|---|---|
Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; Dose-Response Relationship, Drug; Electroencephalography; Hippocampus; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Phosphorylation; Reaction Time; Receptors, AMPA; Receptors, Dopamine D1; Receptors, Dopamine D5; Seizures; Signal Transduction; Threonine; Time Factors | 2008 |
Regulation of DARPP-32 phosphorylation by three distinct dopamine D1-like receptor signaling pathways in the neostriatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cyclosporine; Dopamine Agents; Dopamine and cAMP-Regulated Phosphoprotein 32; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Estrenes; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Models, Biological; Neostriatum; Phosphorylation; Pyrrolidinones; Receptors, Dopamine D1; Signal Transduction; Threonine; Time Factors | 2008 |